© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
China Medicine Corp. (CHME) stock declined over -18.92%, trading at $0.03 on OTC, down from the previous close of $0.04. The stock opened at $0.04, fluctuating between $0.03 and $0.04 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 0.04 | 0.04 | 0.03 | 0.03 | 154.25K |
| Sep 09, 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 5K |
| Sep 08, 2026 | 0.04 | 0.05 | 0.04 | 0.05 | 14.13K |
| Sep 04, 2026 | 0.06 | 0.06 | 0.06 | 0.06 | 690 |
| Aug 28, 2026 | 0.05 | 0.06 | 0.05 | 0.06 | 104.17K |
| Aug 19, 2026 | 0.05 | 0.05 | 0.05 | 0.05 | 100 |
| Aug 18, 2026 | 0.06 | 0.06 | 0.05 | 0.05 | 3.1K |
| Aug 17, 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 23.36K |
| Aug 07, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 20K |
| Aug 04, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 32K |
| Jul 29, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 3K |
| Jul 23, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 900 |
| Jun 30, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 25.9K |
| Jun 29, 2026 | 0.03 | 0.03 | 0.02 | 0.02 | 60.5K |
| Jun 11, 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 30K |
| Jun 10, 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 20K |
| Jun 09, 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 45K |
| Jun 08, 2026 | 0.04 | 0.04 | 0.03 | 0.03 | 60K |
| Jan 06, 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 17.5K |
| Jan 02, 2026 | 0.04 | 0.04 | 0.03 | 0.03 | 50K |
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
| Employees | 281 |
| Beta | -8.66 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |